Medivie Therapeutic Ltd Cash Flow Conversion Efficiency
Medivie Therapeutic Ltd cash flow conversion efficiency. Based on the latest financial reports, Medivie Therapeutic Ltd (MDVI) has a cash flow conversion efficiency ratio of 0.217x as of June 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-966.00K ≈ $-2.59K USD) by net assets (ILA-4.46 Million ≈ $-11.95K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medivie Therapeutic Ltd (2010–2020)
Cash flow conversion efficiency of Medivie Therapeutic Ltd from 2010 to 2020. This chart illustrates how Medivie Therapeutic Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medivie Therapeutic Ltd (MDVI) stock price for real-time trading data and today's change.
Medivie Therapeutic Ltd Cash Flow Conversion Ratio Explained
Medivie Therapeutic Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medivie Therapeutic Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medivie Therapeutic Ltd ranked by their cash flow conversion efficiency. Also see Medivie Therapeutic Ltd market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fast Finance SA
WAR:FFI
|
0.388x |
|
Riverstone Energy Ltd
LSE:RSE
|
0.499x |
|
RTL Group SA
LSE:0MNC
|
-0.003x |
|
GeoVax Labs Inc
NASDAQ:GOVX
|
-1.266x |
|
IXICO PLC
LSE:IXI
|
-0.118x |
|
Pimpinan Eshan Bhd
KLSE:5622
|
-0.010x |
|
Actelis Networks Inc.
NASDAQ:ASNS
|
-0.816x |
|
Mavshack publ AB
ST:MAV
|
-0.181x |
Annual Cash Flow Conversion Efficiency for Medivie Therapeutic Ltd (2010–2020)
The table below shows the annual cash flow conversion efficiency of Medivie Therapeutic Ltd from 2010 to 2020. Review financial flexibility index of Medivie Therapeutic Ltd to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-12-31 | ILA3.73 Million ≈ $10.00K |
ILA-3.88 Million ≈ $-10.41K |
-1.041x | -81.64% |
| 2019-12-31 | ILA5.88 Million ≈ $15.76K |
ILA-3.37 Million ≈ $-9.03K |
-0.573x | -38.84% |
| 2018-12-31 | ILA12.18 Million ≈ $32.65K |
ILA-5.03 Million ≈ $-13.48K |
-0.413x | -127.05% |
| 2017-12-31 | ILA16.26 Million ≈ $43.60K |
ILA-2.96 Million ≈ $-7.93K |
-0.182x | +97.06% |
| 2016-12-31 | ILA577.00K ≈ $1.55K |
ILA-3.57 Million ≈ $-9.58K |
-6.194x | -192.21% |
| 2015-12-31 | ILA-527.00K ≈ $-1.41K |
ILA-3.54 Million ≈ $-9.49K |
6.717x | +605.14% |
| 2014-12-31 | ILA2.26 Million ≈ $6.05K |
ILA-3.00 Million ≈ $-8.04K |
-1.330x | -172.72% |
| 2013-12-31 | ILA-1.52 Million ≈ $-4.08K |
ILA-2.79 Million ≈ $-7.47K |
1.829x | +117.83% |
| 2012-12-31 | ILA1.22 Million ≈ $3.27K |
ILA-12.52 Million ≈ $-33.57K |
-10.254x | -172.59% |
| 2011-12-31 | ILA3.65 Million ≈ $9.80K |
ILA-13.74 Million ≈ $-36.85K |
-3.762x | -321.61% |
| 2010-12-31 | ILA-5.68 Million ≈ $-15.24K |
ILA-9.65 Million ≈ $-25.87K |
1.697x | -- |
About Medivie Therapeutic Ltd
Medivie Therapeutic Limited develops and markets dental devices. It offers Laboraide, a dental device that is placed between the woman's lower and upper jaw during birth, which allows the relaxation of the jaw, neck, and head muscles through the flow of oxygen to the muscles. The company also develops modular pacifiers that enables development of mouth structure and prevent future damage to the c… Read more